Request for Tender – Supply of Imported Plasma and Recombinant Blood Products
Tender ID: 387955
Tender Details
Tender Description
The aim of this procurement is to establish new supply arrangements for SHL and EHL rFVIII and rFIX products.
Successful tenderers will be required to supply rFVIII or rFIX products to meet orders from health providers in Australia, maintain contractually required supply security reserves, and provide a range of product support services.
The release of this Request for Tender follows consultation with clinical stakeholders and potential suppliers in January 2017. Key points identified from the consultation process and other market intelligence are as follows:
* In general, there is continued support for access to a secure supply of the safest and most efficacious therapies with a preference for EHL products.
* Administration kits and support material are not supplied for some products.
* The importance of patient access to products with administration devices suitable to all patients with different degrees of dexterity.
* A number of potential new product variants including SHL and EHL products, bypassing therapies to treat patients with inhibitors, monoclonal antibodies and gene therapy.
Location
Similar Tenders
Active opportunities matching this tender's categories and regions.